课题基金 / 基金详情

Characterisation of the role of mesenchymal phenotypes and EGFR in treatment-resistant melanoma.

Characterisation of the role of mesenchymal phenotypes and EGFR in treatment-resistant melanoma.
间充质表型和 EGFR 在难治性黑色素瘤中作用的表征。
批准号:
nhmrc : GNT1055456
负责人:
Dr Miles Andrews
金额:
$11.32万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Postgraduate Scholarships
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-01-01 至 --

项目摘要

项目成果

Dr Miles Andrews的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Phenotypic change has been identified in multiple settings relating to melanoma progression and metastasis. We have identified a degree of overlap between features of phenotypic plasticity, epithelial-to-mesenchymal transition, and the emergence of treatment resistance. This project will further examine mechanisms underlying these changes, focusing on the role of the epidermal growth factor.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deriving actionable strategies to enhance cancer immunotherapy response
  • 批准号:
    nhmrc : 1148680
  • 项目类别:
    Early Career Fellowships
  • 资助金额:
    $29.82万
  • 财政年份:
    2018
  • 负责人:
    Dr Miles Andrews
  • 依托单位:
Deriving actionable strategies to enhance cancer immunotherapy response
  • 批准号:
    nhmrc : GNT1148680
  • 项目类别:
    Early Career Fellowships
  • 资助金额:
    $43.88万
  • 财政年份:
    2018
  • 负责人:
    Dr Miles Andrews
  • 依托单位:
Non-mutational phenotypic evolution in metastatic melanoma: the role of the epidermal growth factor receptor and epithelial-mesenchymal transition-like processes in treatment resistance.
  • 批准号:
    nhmrc : 1055456
  • 项目类别:
    Postgraduate Scholarships
  • 资助金额:
    $9.4万
  • 财政年份:
    2013
  • 负责人:
    Dr Miles Andrews
  • 依托单位:
国内基金
海外基金
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
Sestrin2抑制内质网应激对早产儿视网膜病变的调控作用及其机制研究
  • 批准号:
    82371070
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵培泉
  • 依托单位: